ORIGINAL RESEARCH
Accepted on 04 Aug 2025
Counterregulatory Response to Hypoglycemia During a Hypoglycemic Clamp in People with Type 2 Diabetes Treated with Tirzepatide
doi 10.3389/fendo.2025.1627947
- 221 views
- Frontiers in Endocrinology
- Diabetes: Molecular Mechanisms
- Research Topics
- The Impact of GIP/GIPR on Metabolic Diseases: How the Field Is Evolving
The Impact of GIP/GIPR on Metabolic Diseases: How the Field Is Evolving
15k
Total downloads
67k
Total views and downloads
Articles
REVIEW
Published on 21 May 2025
The evolution of the therapeutic concept ‘GIP receptor antagonism’
doi 10.3389/fendo.2025.1570603
- 2,714 views
REVIEW
Published on 17 Mar 2025
The role of GIPR in food intake control
doi 10.3389/fendo.2025.1532076
- 4,222 views
REVIEW
Published on 03 Feb 2025
The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
doi 10.3389/fendo.2025.1530985
- 2,451 views
- 3 citations
REVIEW
Published on 24 Jul 2024
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
doi 10.3389/fendo.2024.1431292
- 40,322 views
- 48 citations
REVIEW
Published on 24 Jun 2024
Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence
doi 10.3389/fendo.2024.1402583
- 11,724 views
- 13 citations
